BCBS Opioid Abuse Plan Requires Authorization For Scripts Longer than 30 Days
This article was originally published in The Pink Sheet Daily
Executive Summary
Blue Cross Blue Shield of Massachusetts is implementing what it believes are industry-leading policies July 1 to restrain the abuse of opioid medications among its members.
You may also be interested in...
Part D "Doctor Shopping": GAO's Remedies Find Little Buy-In From CMS
A Senate hearing examining the prevalence of “doctor shopping” by Medicare Part D enrollees revealed that CMS and the Government Accountability Office disagree on possible tools to address the issue, and perhaps more basically, who is responsible for implementing them.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Khan Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.